NIH/NIA: Multimorbidity in Alzheimer’s disease impacts choice of ancillary treatments

This aims to improve the effectiveness of treatment strategies for comorbid conditions that occur frequently in combination with Alzheimer’s disease and related dementia. View details

ARUK: Prevention and Risk Reduction Fund

The Prevention and Risk Reduction Fund provides funds for primary prevention and risk reduction research that have potential to significantly alter the course of cognitive decline in populations th View details

NIH/NIA: Selective cell and network vulnerability in ageing and Alzheimer’s disease

The goal of this FOA is to define and characterize neural cell populations, neural circuits, and brain networks and regions that are vulnerable to brain aging and Alzheimer’s disease (AD). View details

PPI Ignite Awards 2017 - Supporting Public and Patient Involvement in Research

  Link: View details

National Institutes of Health - National Institute on Aging

Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease (R01) View details